| EMBL Course: Circulating Tumour DNA in Clinical Applications | |
|
Germany - Heidelberg |
|
| Hosted by: | EMBL Events |
| Venue: | EMBL Advanced Training Centre |
| Dates: | Mar 09, 2020 through Mar 12, 2020 |
|
Description |
|
| Minimally invasive liquid biopsies have recently emerged as novel diagnostic methods which hold the promise to monitor disease progression, detect minimal residual disease, therapy resistance and potentially even early cancer detection. Participants will gain hands-on experience in the detection of cell free tumor DNA (cfDNA) using a next generation sequencing (NGS) approach that covers all four mutation classes in a single assay. Critical aspects on recent developments to increase analytical sensitivity and mitigate sequencing errors (computational error correction) will be discussed as well as annotation, interpretation, and clinical reporting of liquid biopsy tests. Lectures will cover the evaluation of ctDNA as biomarkers, clinical applications, emerging analytes for liquid biopsy and important challenges. | |
| Additional Information | |
| Event URL: | https://www.embl.de/training/events/2020/CNA20-01/ |
| ISCB Member Discount: | None |
| Contact Person: | EMBL Events ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.
